Kellum JA
University of Pittsburgh Medical Center, Division of Critical Care Medicine, 200 Lothrop Street, Pittsburgh, PA 15213-2582, USA.
Crit Care. 1997;1(2):53-59. doi: 10.1186/cc103.
To evaluate the impact of diuretics and dopamine for both the prevention and treatment of renal dysfunction in the acute care setting. STUDY IDENTIFICATION AND SELECTION: Studies were identified via MEDLINE, and through bibliographies of primary and review articles. Articles were then screened by the author for studies addressing the use of diuretics or dopamine in the prevention and/or treatment of renal dysfunction. DATA ABSTRACTION AND LITERATURE APPRAISAL: From individual studies, data were abstracted regarding design features, population, intervention and outcomes. Studies were graded by levels according to their design. RESULTS: A total of 10 studies using diuretics and 30 involving dopamine were identified. Level I evidence exists against the use of diuretics for radiocontrast-induced acute tubular necrosis, and loop diuretics given after vascular surgery. There is level II evidence that diuretics do not improve outcome in patients with established acute renal failure. Level II evidence also exists against the use of dopamine in the prevention of acute tubular necrosis in multiple subsets of patients. CONCLUSIONS: Routine use of diuretics or dopamine for the prevention of acute renal failure cannot be justified on the basis of available evidence.
评估利尿剂和多巴胺在急性护理环境中预防和治疗肾功能障碍的作用。
通过医学文献数据库(MEDLINE)以及原始文章和综述文章的参考文献来识别研究。然后作者筛选文章,以查找涉及使用利尿剂或多巴胺预防和/或治疗肾功能障碍的研究。
从各项研究中提取有关设计特点、研究对象、干预措施和结果的数据。根据研究设计对研究进行分级。
共识别出10项使用利尿剂的研究和30项涉及多巴胺的研究。有一级证据反对将利尿剂用于造影剂诱导的急性肾小管坏死以及血管手术后使用袢利尿剂。有二级证据表明利尿剂不能改善已确诊急性肾衰竭患者的预后。也有二级证据反对在多个患者亚组中使用多巴胺预防急性肾小管坏死。
根据现有证据,常规使用利尿剂或多巴胺预防急性肾衰竭并无依据。